These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6590014)

  • 1. The Nottingham Research Programme in breast cancer.
    Blamey RW
    Aust N Z J Surg; 1984 Jun; 54(3):191-9. PubMed ID: 6590014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic strategies in the treatment of breast cancer (author's transl)].
    Huber H; Gattringer C; Grünewald K; Margreiter R; Mikuz G; Frommhold H; Senn HJ; Braunsteiner H
    Wien Klin Wochenschr; 1981 Sep; 93(17):531-41. PubMed ID: 7303699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral synchronous breast cancer. A clinical dilemma.
    Guraya SY; Khairy GA
    Saudi Med J; 2004 Dec; 25(12):2024-5. PubMed ID: 15711694
    [No Abstract]   [Full Text] [Related]  

  • 4. Current strategies in operable breast cancer.
    Deckers PJ
    Hosp Pract (Off Ed); 1987 Jan; 22(1A):41-9, 53-4, 59-68. PubMed ID: 3100553
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.
    Sterns EE; Cochran AJ
    Surg Gynecol Obstet; 1989 Jul; 169(1):81-98. PubMed ID: 2662454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: scientific basis of adjuvant chemotherapy in breast cancer.
    Griswold DP
    Recent Results Cancer Res; 1984; 96():46-7. PubMed ID: 6528091
    [No Abstract]   [Full Text] [Related]  

  • 7. Some changing concepts of the natural history of human mammary cancer and their effect on diagnosis and treatment.
    Tagnon HJ
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):123-8. PubMed ID: 3514230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular subtypes and individualized treatment of breast cancer].
    Xu BH; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):641-4. PubMed ID: 21122374
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins.
    Bennett A; Berstock DA; Carroll MA; Stamford IF; Wilson AJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():299-302. PubMed ID: 6221606
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.
    Fisher B; Redmond CK; Fisher ER
    J Clin Oncol; 2008 May; 26(13):2068-71. PubMed ID: 18445835
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins and prognosis in human breast cancer.
    Watson DM; Kelly RW; Miller WR
    Br J Cancer; 1987 Sep; 56(3):367-70. PubMed ID: 3478073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptors and breast cancer.
    Nicholson RI; Griffiths K; Blamey RW; Bishop HM; Haybittle JL
    Environ Health Perspect; 1981 Apr; 38():143-6. PubMed ID: 7238443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study.
    Copson E; Eccles B; Maishman T; Gerty S; Stanton L; Cutress RI; Altman DG; Durcan L; Simmonds P; Lawrence G; Jones L; Bliss J; Eccles D;
    J Natl Cancer Inst; 2013 Jul; 105(13):978-88. PubMed ID: 23723422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the treatment of advanced breast cancer: therapeutic modalities at the National Cancer Center Hospital].
    Adachi I; Suzuki M; Tsuchihashi T; Yamaguchi K; Abe K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):793-800. PubMed ID: 3566292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer recurrences and metastases].
    Bazhenova AP; Kachanov IP
    Khirurgiia (Mosk); 1980 Apr; (4):7-12. PubMed ID: 7374084
    [No Abstract]   [Full Text] [Related]  

  • 18. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of primary breast cancer: an overview.
    Forrest AP
    Prog Clin Biol Res; 1977; 12():313-20. PubMed ID: 918108
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical symptoms of cancer and precancerous diseases of the breast].
    Shaĭkhiev USh; Sidzhanov ZhM; Pamurzin LG
    Vopr Onkol; 1978; 24(8):26-31. PubMed ID: 695421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.